Portage Biotech (PRTG) Short Interest Ratio & Short Volume → Elon’s New Device is About to Shock the World (From InvestorPlace) (Ad) Free PRTG Stock Alerts $0.29 -0.02 (-6.47%) (As of 05/8/2024 ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestSocial Media Portage Biotech Short Interest DataCurrent Short Volume8,400 sharesPrevious Short Volume6,500 sharesChange Vs. Previous Month+29.23%Dollar Volume Sold Short$2,856.00Short Interest Ratio / Days to Cover0.1Last Record DateApril 15, 2024Outstanding Shares17,800,000 sharesFloat Size8,670,000 sharesShort Percent of Float0.10%Today's Trading Volume94,971 sharesAverage Trading Volume87,883 sharesToday's Volume Vs. Average108% Short Selling Portage Biotech ? Sign up to receive the latest short interest report for Portage Biotech and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatPRTG Short Interest Over TimePRTG Days to Cover Over TimePRTG Percentage of Float Shorted Over Time Ad InvestorPlace$21,000 in profits in six weeks? On Wednesday, May 8, the legendary Jonathan Rose is holding his first ever Masters in Trading Summit. Jonathan is one of the sharpest traders I’ve ever met. He made millions trading in the pits of the world’s largest exchanges.Click here for details. Portage Biotech Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/15/20248,400 shares $2,856.00 +29.2%0.1%0.1 $0.34 3/31/20246,500 shares $3,661.45 -57.8%0.1%0.1 $0.56 3/15/202415,400 shares $8,470.00 -84.6%0.2%0.2 $0.55 2/29/2024100,200 shares $59,118.00 +902.0%1.2%1.8 $0.59 2/15/202410,000 shares $6,005.00 -9.1%0.1%0.2 $0.60 1/31/202411,000 shares $9,571.10 +44.7%0.1%0.3 $0.87 Get the Latest News and Ratings for PRTG and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Portage Biotech and its competitors with MarketBeat's FREE daily newsletter. 1/15/20247,600 shares $8,208.00 +16.9%0.1%0.2 $1.08 12/31/20236,500 shares $11,830.00 -63.1%0.1%0.2 $1.82 12/15/202317,600 shares $22,352.00 -25.4%0.2%0.5 $1.27 11/30/202323,600 shares $31,034.00 -56.4%0.3%0.8 $1.32 11/15/202354,100 shares $78,445.00 +4.4%0.7%2 $1.45 10/31/202351,800 shares $102,823.00 -8.3%0.6%2.3 $1.99 10/15/202356,500 shares $119,780.00 +4.2%0.7%2.5 $2.12 9/30/202354,200 shares $113,278.00 +32.2%0.7%2.9 $2.09 9/15/202341,000 shares $118,490.00 +494.2%0.5%2.9 $2.89 8/31/20236,900 shares $17,664.00 -27.4%0.1%0.5 $2.56 8/15/20239,500 shares $22,800.00 +30.1%0.1%0.7 $2.40 7/31/20237,300 shares $23,506.00 +1.4%0.1%0.5 $3.22 7/15/20237,200 shares $24,408.00 +22.0%0.1%0.5 $3.39 6/30/20235,900 shares $20,591.00 -24.4%0.1%0.4 $3.49 6/15/20237,800 shares $28,860.00 -1.3%0.1%0.4 $3.70 5/31/20237,900 shares $27,492.00 -75.8%0.1%0.3 $3.48 5/15/202332,600 shares $104,646.00 -10.4%0.4%1.3 $3.21 4/30/202336,400 shares $121,576.00 -34.8%0.5%1.3 $3.34 4/15/202355,800 shares $175,770.00 +5.5%0.7%1.7 $3.15 3/31/202352,900 shares $163,461.00 +32.6%0.7%1.5 $3.09 3/15/202339,900 shares $119,700.00 -6.8%0.5%1.1 $3.00 2/28/202342,800 shares $163,496.00 -9.1%0.5%1.1 $3.82 2/15/202347,100 shares $198,762.00 -3.1%0.4%1.3 $4.22 1/31/202348,600 shares $250,290.00 +7.5%0.4%1.4 $5.15 1/15/202345,200 shares $246,150.16 -11.2%0.3%1.7 $5.45 12/30/202250,900 shares $269,261.00 +7.4%0.4%2.1 $5.29 12/15/202247,400 shares $237,000.00 -0.8%0.4%2.3 $5.00 11/30/202247,800 shares $281,064.00 +2.6%0.4%2.6 $5.88 11/15/202246,600 shares $280,066.00 +2.4%0.4%3.2 $6.01 10/31/202245,500 shares $298,935.00 -23.1%0.3%3.2 $6.57 10/15/202259,200 shares $400,192.00 +11.1%0.9%3.9 $6.76 9/30/202253,300 shares $363,506.00 +1.0%0.8%3.3 $6.82 9/15/202252,800 shares $414,480.00 -23.6%0.8%2 $7.85 8/31/202269,100 shares $532,761.00 +0.4%1.4%2.3 $7.71Elon’s New Device is About to Shock the World (Ad)Using this device you see above… Elon Musk just tested a new type of A.I. that according to Wired Magazine will usher in… “The next step in human evolution.” Click here to see the details because there’s a lot of money at stake. PRTG Short Interest - Frequently Asked Questions What is Portage Biotech's current short interest? Short interest is the volume of Portage Biotech shares that have been sold short but have not yet been covered or closed out. As of April 15th, traders have sold 8,400 shares of PRTG short. 0.10% of Portage Biotech's shares are currently sold short. Learn More on Portage Biotech's current short interest. What is a good short interest percentage for Portage Biotech? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 0.10% of Portage Biotech's floating shares are currently sold short. Is Portage Biotech's short interest increasing or decreasing? Portage Biotech saw a increase in short interest during the month of April. As of April 15th, there was short interest totaling 8,400 shares, an increase of 29.2% from the previous total of 6,500 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Portage Biotech's float size? Portage Biotech currently has issued a total of 17,800,000 shares. Some of Portage Biotech's outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Portage Biotech currently has a public float of 8,670,000 shares. How does Portage Biotech's short interest compare to its competitors? 0.10% of Portage Biotech's shares are currently sold short. Here is how the short interest of companies in the sector of "medical" compare to Portage Biotech: Ensysce Biosciences, Inc. (0.14%), Genprex, Inc. (2.69%), Longeveron Inc. (9.34%), Tharimmune, Inc. (0.90%), Bright Minds Biosciences Inc. (2.76%), Artelo Biosciences, Inc. (0.19%), Sharps Technology, Inc. (2.47%), Acutus Medical, Inc. (2.92%), Venus Concept Inc. (0.32%), Exicure, Inc. (2.01%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.70 billion), Occidental Petroleum Co. ($3.52 billion), Charter Communications, Inc. ($3.14 billion), General Motors ($2.68 billion), Coinbase Global, Inc. ($2.57 billion), Moderna, Inc. ($2.18 billion), Tractor Supply ($2.10 billion), Royal Caribbean Cruises Ltd. ($1.91 billion), TC Energy Co. ($1.90 billion), and Williams-Sonoma, Inc. ($1.78 billion). View all of the most shorted stocks. What does it mean to sell short Portage Biotech stock? Short selling PRTG is an investing strategy that aims to generate trading profit from Portage Biotech as its price is falling. PRTG shares are trading down $0.02 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Portage Biotech? A short squeeze for Portage Biotech occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of PRTG, which in turn drives the price of the stock up even further. How often is Portage Biotech's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including PRTG, twice per month. The most recent reporting period available is April, 15 2024. More Short Interest Resources from MarketBeat Related Companies: ENSC Short Squeeze GNPX Short Squeeze LGVN Short Squeeze THAR Short Squeeze DRUG Short Squeeze ARTL Short Squeeze STSS Short Squeeze AFIB Short Squeeze VERO Short Squeeze XCUR Short Squeeze Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:PRTG) was last updated on 5/8/2024 by MarketBeat.com Staff From Our PartnersThe #1 Biotech Stock to Watch in 2024 is Attacking Viruses in a Unique WaySmallcaps DailyTech GIANT’s Plans to Revolutionize Crypto…Crypto 101 MediaAI “wealth window” is closing June 25thParadigm PressThe 2024 Gold Rush: Unleashing Market PotentialPriority GoldHe Is Giving Away BitcoinCrypto Swap ProfitsGold Set to EXPLODE!Gold Safe ExchangeCharles Payne Demystifies OptionsUnstoppable ProsperityShocking: One AI startup's revenue could surge 4,735%Manward Press